JSH Guidelines for the Management of Hepatitis C Virus Infection, 2019 Update; Protective Effect of Antiviral Therapy against Hepatocarcinogenesis-Reference-Cited by-同舟云学术

JSH Guidelines for the Management of Hepatitis C Virus Infection, 2019 Update; Protective Effect of Antiviral Therapy against Hepatocarcinogenesis

Published:2020-05-18 Issue:7 Volume:50 Page:775-790
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Asahina Yasuhiro,

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13501

Reference101 articles.

1. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis

2. Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

3. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C;Kasahara A;Osaka Liver Disease Study Group Hepatology,1998

4. Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan

5. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral eradication reduces all‐cause mortality in patients with chronic hepatitis C virus infection who had received direct‐acting antiviral therapy;Liver International;2024-09-02

2. Low risk of hepatitis B virus reactivation in membranous nephropathy patients with resolved infection undergoing rituximab-based regimens without antiviral prophylaxis;International Immunopharmacology;2024-09

3. Serum Mac‐2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virus;Journal of Gastroenterology and Hepatology;2024-07-10

4. Grip strength complements performance status in assessing general condition in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab;Hepatology Research;2024-06-15

5. Positive impact of obesity on the prognosis of liver cirrhosis;Journal of Gastroenterology and Hepatology;2024-05-03